On September 28 uniMIND Central Session will host Mauro Cavarra for an open discussion on our recently published paper reviewing the different models of psychedelic-assisted psychotherapy used in clinical trials. The session will start at 7pm (CEST) and anyone is welcome to join via the MIND Community Platform.
What do we mean when we say Psychedelic-Assisted Psychotherapy (PAP)? While some general guidelines to conduct PAP treatment programs are quite established and agreed upon, the degree of variability within the preparation - drug session - integration model is still very high. Our latest publication collects, compares and analyses the different therapeutic approaches that are… Continue reading Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Dr. Kim Kuypers and Natasha Mason were invited to speak at and participate in an event in Helsinki, Finland, discussing research on the therapeutic potential and mechanisms of action of psilocybin and MDMA. The panel discussion has now been posted, and can be viewed here.
Pint of Science is coming to the Netherlands this year, and we will be sharing some of our research! If you are in the Maastricht area on May 20th, come to Cafe Charlemagne to hear about "the good, the bad, and the intoxicated". For full event info, check out the website.
Algemeen Dagblad 01/06/2018 Ketamine tegen je depressie of MDMA zodat je ineens wel over je gevoelens kunt praten bij de psycholoog? Klinkt niet als een recept wat je bij de apotheek om de hoek haalt, toch? Als het aan Prof. Dr. Jan Ramaekers en collega’s ligt, is dit in de nabije toekomst wel het geval.… Continue reading Professor: psychiaters schrijven in toekomst partydrugs voor
